Fibriclotte

Human Fibrinogen (Fibriclotte) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for patients with fibrinogen deficiencies.

Human Fibrinogen, such as Fibriclotte, is primarily used to treat bleeding episodes in patients with congenital fibrinogen deficiency. It may also be used during surgery to prevent excessive blood loss. This medication works by replenishing fibrinogen levels in the blood, aiding in the formation of blood clots.

Common effects of Human Fibrinogen may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild fever or chills. These effects are generally temporary and subside quickly.

Human Fibrinogen should be administered under medical supervision. Patients with a history of allergic reactions to blood products should use this medication with caution. It is essential to inform healthcare providers about any existing medical conditions or medications before use.

Human Fibrinogen may interact with other blood-thinning medications or anticoagulants. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood clotting.